11/14/2024
2:13 PM | IDEAYA Biosciences, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:15 PM | 4D Molecular Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:16 PM | CARGO Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:17 PM | AMDOCS LTD (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:19 PM | Janus Henderson Group (Filed by)
LIGAND PHARMACEUTICALS INC (Subject)
| Form SC 13G/A | |
11/14/2024
2:20 PM | BLACKBAUD INC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:24 PM | Janus Henderson Group (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
| Form SC 13G/A | |
|
11/14/2024
1:55 PM | Janus Henderson Group (Filed by)
ZIFF DAVIS, INC. (Subject)
| Form SC 13G/A | |
11/14/2024
1:57 PM | Ascendis Pharma A/S (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:05 PM | FLEX LTD. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:06 PM | Biohaven Ltd. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
2:08 PM | Janus Henderson Group (Filed by)
SS&C Technologies Holdings Inc (Subject)
| Form SC 13G/A | |
11/14/2024
2:09 PM | Janus Henderson Group (Filed by)
Sensata Technologies Holding plc (Subject)
| Form SC 13G/A | |
11/14/2024
2:11 PM | GLOBUS MEDICAL INC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
1:53 PM | Janus Henderson Group (Filed by)
Vaxcyte, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
1:54 PM | Janus Henderson Group (Filed by)
OSI SYSTEMS INC (Subject)
| Form SC 13G/A | |
11/14/2024
11:28 AM | CytomX Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
11:30 AM | IMMUNIC, INC. (Subject)
IMMUNIC, INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
11:32 AM | Janus Henderson Group (Filed by)
Lexeo Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
11:39 AM | Janus Henderson Group (Filed by)
TENAX THERAPEUTICS, INC. (Subject)
| Form SC 13G/A | |
11/14/2024
11:47 AM | 89bio, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:44 AM | Janus Henderson Group (Filed by)
Mereo BioPharma Group plc (Subject)
| Form SC 13G/A | |
11/14/2024
10:49 AM | Consensus Cloud Solutions, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:50 AM | AVADEL PHARMACEUTICALS PLC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:33 AM | Janus Henderson Group (Filed by)
TELEFLEX INC (Subject)
| Form SC 13G/A | |
11/14/2024
10:35 AM | CIMPRESS plc (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:36 AM | Janus Henderson Group (Filed by)
WEX Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
10:38 AM | ICU MEDICAL INC/DE (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:41 AM | Janus Henderson Group (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
10:27 AM | Beauty Health Co (Subject)
Beauty Health Co (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
10:10 AM | Janus Henderson Group (Filed by)
PepGen Inc. (Subject)
| Form SC 13G | |
11/14/2024
10:11 AM | Janus Henderson Group (Filed by)
Zai Lab Ltd (Subject)
| Form SC 13G | |
11/14/2024
9:44 AM | ASURE SOFTWARE INC (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:54 AM | Janus Henderson Group (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
11/14/2024
9:25 AM | EAGLE PHARMACEUTICALS, INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
9:26 AM | Janus Henderson Group (Filed by)
Structure Therapeutics Inc. (Subject)
| Form SC 13G | |
11/14/2024
9:28 AM | Dyne Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:29 AM | Aramark (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:31 AM | Caesars Entertainment, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:33 AM | Immunome Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
11/14/2024
9:36 AM | Janus Henderson Group (Filed by)
NEOGENOMICS INC (Subject)
| Form SC 13G | |
2024's Must-Watch Stocks! (Ad) Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.  [Unlock Your Report Now] |
11/14/2024
9:37 AM | Janus Henderson Group (Filed by)
REVVITY, INC. (Subject)
REVVITY, INC. (Subject)
| Form SC 13G | |
11/14/2024
9:39 AM | Janus Henderson Group (Filed by)
RENTOKIL INITIAL PLC /FI (Subject)
RENTOKIL INITIAL PLC /FI (Subject)
| Form SC 13G | |
11/14/2024
8:59 AM | ABEONA THERAPEUTICS INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
9:00 AM | Compass Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
9:02 AM | Janus Henderson Group (Filed by)
Skye Bioscience, Inc. (Subject)
Skye Bioscience, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
9:24 AM | Janus Henderson Group (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics, Inc. (Subject)
| Form SC 13G | |
11/14/2024
8:56 AM | Janus Henderson Group (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
8:50 AM | Catalent, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
8:53 AM | CONSTELLIUM SE (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024
8:40 AM | Janus Henderson Group (Filed by)
Sarepta Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
6:46 AM | Janus Henderson Group (Subject)
Silchester International Investors LLP (Filed by)
| Form SC 13G/A | |
11/08/2024
3:08 PM | CASSIDY WILLIAM B (Reporting)
Janus Henderson Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
3:41 PM | Janus Henderson Group (Issuer)
ROSENBERG MICHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
2:13 PM | Janus Henderson Group (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
11/06/2024
2:26 PM | Benitec Biopharma Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/04/2024
1:17 PM | Janus Henderson Group (Subject)
ROSENBERG MICHELLE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
1:19 PM | Benitec Biopharma Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
10/03/2024
8:55 AM | Janus Henderson Group (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13G | |
09/12/2024
6:46 PM | Janus Henderson Group (Issuer)
THOMPSON ROGER MJ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:44 PM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
4:09 PM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
9:43 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
6:41 PM | Janus Henderson Group (Filer)
| Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company | |
08/20/2024
5:24 PM | Janus Henderson Group (Issuer)
ROSENBERG MICHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
1:23 PM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
9:56 AM | Janus Henderson Group (Subject)
ROSENBERG MICHELLE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
2:19 PM | Janus Henderson Group (Filed by)
TENAX THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
08/14/2024
9:48 AM | Janus Henderson Group (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
08/12/2024
8:06 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
2:30 PM | Consensus Cloud Solutions, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
08/09/2024
11:06 AM | Janus Henderson Group (Filed by)
WEX Inc. (Subject)
| Form SC 13G/A | |
08/05/2024
11:54 AM | Janus Henderson Group (Filed by)
Lexeo Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
08/01/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
9:50 AM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
6:38 PM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
6:10 PM | ARCA biopharma, Inc. (Issuer)
ARCA biopharma, Inc. (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
Janus Henderson Group (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2024
10:46 AM | Janus Henderson Group (Filed by)
Mereo BioPharma Group plc (Subject)
| Form SC 13G | |
07/10/2024
12:12 PM | Janus Henderson Group (Filed by)
Mirum Pharmaceuticals, Inc. (Subject)
| Form SC 13G | |
07/05/2024
4:20 PM | ARCA biopharma, Inc. (Subject)
ARCA biopharma, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
06/20/2024
4:22 PM | Janus Henderson Group (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/18/2024
10:37 AM | Dibadj Ali (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:17 PM | Akero Therapeutics, Inc. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G/A | |
06/07/2024
2:01 PM | CRAWFORD BERG (Reporting)
Janus Henderson Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/30/2024
4:04 PM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
2:06 PM | ABEONA THERAPEUTICS INC. (Subject)
Janus Henderson Group (Filed by)
| Form SC 13G | |
05/07/2024
4:30 PM | DOLAN KEVIN B (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:24 PM | DOLAN KEVIN B (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
2024's Must-Watch Stocks! (Ad) Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] |
05/06/2024
3:45 PM | Janus Henderson Group (Issuer)
Quirk Alison A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:30 PM | Janus Henderson Group (Issuer)
Sheehan Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
1:08 PM | Janus Henderson Group (Issuer)
SEYMOUR JACKSON ANGELA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
12:15 PM | CASSADAY JOHN M (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
12:44 PM | FLOOD EUGENE JR (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
11:43 AM | Janus Henderson Group (Issuer)
Seidman Leslie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
12:08 PM | DESAI KALPANA (Reporting)
Janus Henderson Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:30 AM | Janus Henderson Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
